
Business model


LakeShore Biopharma Granted Phase III Clinical Trial Approval to Explore Simplified Regimens for YSJA Rabies Vaccine
LakeShore Biopharma Co., Ltd.


Ashling Partners Wins Celonis Partner of the Year at Celosphere 2024
Ashling Partners



WEXIT: Wealthy Brits Exit UK for EU Ahead of Budget
Henley & Partners



LG SHOWCASES SELF-DRIVING AI HOME HUB AT ROSCON 2024
LG Electronics, Inc.